Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Himachal, UP Join States Banning Coldrif Cough Syrup After MP Deaths

Health Ministry Bans 34 Key Antibiotics, Antivirals for Animal Use, See List

Susmita Roy29 Sept 2025 9:51 PM IST

New Delhi: Through a recent Gazette notification, the Ministry of Health and Family Welfare has notified a ban on the import, manufacture, sale, and...

Delhi ITAT Deletes Rs 14.98 Cr Ad-Hoc Disallowance on Mankind Pharma's Travel Expenses

Susmita Roy28 Sept 2025 3:00 PM IST

New Delhi: The Income Tax Appellate Tribunal (ITAT), Delhi Bench, has set aside the 80% disallowance of travelling and conveyance expenses imposed on...

CDSCO Panel Recommends Updating Prescribing Information for Sanofi's Vaccine

Susmita Roy28 Sept 2025 1:15 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended updation of the...

Trademark Clash: UNWANTED-72 Packaging Blocked, MISTAKE-72 Name Cleared by Delhi HC

Susmita Roy27 Sept 2025 9:40 PM IST

New Delhi: In a trademark dispute between Mankind Pharma Limited and Nectar Biopharma, the Delhi High Court has clarified that Nectar Biopharma cannot...

Not All Combipacks Are New Drugs: CDSCO Defines Approval Rules for Lyophilized Injections

CDSCO Panel Approves Novo Medi Sciences' Phase III Booster Study of PCV13 Pneumococcal Vaccine in Infants

Susmita Roy27 Sept 2025 6:13 PM IST

New Delhi: Reviewing the revised Phase III clinical trial protocol for booster dose administration of the 13-valent Pneumococcal Polysaccharide...

Meghalaya Pharmacists Await Service Rules Even After 50 Years of Statehood

AP EAMCET 2025: B.Pharm, Pharm D Counselling on Hold After HC Directive

Susmita Roy26 Sept 2025 9:00 PM IST

New Delhi: The Andhra Pradesh State Council of Higher Education (APSCHE) has not released the final seat allotment results for B Pharmacy and Pharm D...

Assault upon a Medical Professional Jeopardises the Treatment of Patients Needing Urgent Care: Delhi HC

Setback to Novartis: Delhi HC Rejects Cross-Examination Request in Post-Grant Patent Dispute

Susmita Roy26 Sept 2025 5:18 PM IST

New Delhi: The Delhi High Court on Tuesday sharply criticised Novartis AG's belated attempt to cross-examine opponents' experts in a post-grant patent...

CDSCO Panel Asks Takeda to Submit Full Phase III Data on Dengue Tetravalent Vaccine

Susmita Roy26 Sept 2025 4:21 PM IST

New Delhi: Reviewing India specific blinded interim safety analysis report of the ongoing Phase III clinical trial of Dengue tetravalent vaccine...

Bharat Biotech Gets SEC Nod to Begin Phase III Trial of Inactivated Chikungunya Vaccine

Susmita Roy26 Sept 2025 4:18 PM IST

New Delhi: Noting the results of the Phase II trial for the Inactivated Chikungunya vaccine, the Subject Expert Committee (SEC) functioning under the...

CDSCO Tightens RTI Appeal Timelines, Division Heads to Face Penalties for Lapses

Susmita Roy25 Sept 2025 10:34 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a fresh circular outlining internal timelines and procedures for...

Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug Norms

Patna HC Denies Bail in Codeine Syrup Case: Possession Below 2.5% Still NDPS Offence

Susmita Roy25 Sept 2025 4:50 PM IST

New Delhi: In a significant judgment emphasizing the strict regulatory framework for narcotics, the Patna High Court has refused bail to Nilendra...

Ravenbhel Gets SEC Nod to Market Bilastine, Montelukast FDC, Phase IV Trial Mandated

Syneos Health Asked to Clarify Phase II Tacrolimus Trial Protocol by CDSCO Panel

Susmita Roy25 Sept 2025 3:35 PM IST

New Delhi: Following a thorough review of the Phase II clinical study protocol for Tacrolimus (T1695), the Subject Expert Committee (SEC) functioning...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok